Specific contribution of the erythropoietin gene 3' enhancer to hepatic erythropoiesis after late embryonic stages

Molecular and Cellular Biology

Volumn 31, Issue 18, 2011, Pages 3896-3905

  Suzuki, Norio ^a,b   Obara, Naoshi ^b   Pan, Xiaoqing ^a,b   Watanabe, Miho ^c   Jishage, Kou Ichi ^c   Minegishi, Naoko ^a   Yamamoto, Masayuki ^a,b  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c CHUGAI PHARMACEUTICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN;

ANEMIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DISEASE SEVERITY; EMBRYO DEVELOPMENT; ERYTHROPOIESIS; GENE EXPRESSION; HYPOXIA; IN VIVO STUDY; KIDNEY; MOUSE; MUTANT; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN;

3' FLANKING REGION; ANEMIA; ANIMALS; CHROMATIN IMMUNOPRECIPITATION; ENHANCER ELEMENTS, GENETIC; ERYTHROPOIESIS; ERYTHROPOIETIN; GENE EXPRESSION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE KNOCKOUT TECHNIQUES; HEPATOCYTES; KIDNEY; LIVER; MICE; MICE, TRANSGENIC; POLYMERASE CHAIN REACTION; REGULATORY SEQUENCES, NUCLEIC ACID;

ANIMALIA; MUS; MUS MUSCULUS;

EID: 80052568370     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.05463-11     Document Type: Article

References (51)

1. Araki, K., M. Araki, J. Miyazaki, and P. Vassalli. 1995. Site-specific recombination of a transgene in fertilized eggs by transient expression of Cre recombinase. Proc. Natl. Acad. Sci. U. S. A. 92:160-164.
2. Blanchard, K. L., A. M. Acquaviva, D. L. Galson, and H. F. Bunn. 1992. Hypoxic induction of the human erythropoietin gene: cooperation between the promoter and enhancer, each of which contains steroid receptor response elements. Mol. Cell. Biol. 12:5373-5385.
3. Dame, C., et al. 1998. Erythropoietin mRNA expression in human fetal and neonatal tissue. Blood 92:3218-3225.
4. Dame, C., et al. 2004. Hepatic erythropoietin gene regulation by GATA-4. J. Biol. Chem. 279:2955-2961.
5. Ebert, B. L., and H. F. Bunn. 1999. Regulation of the erythropoietin gene. Blood 94:1864-1877.
6. Ema, M., et al. 1999. Molecular mechanisms of transcription activation by HLF and HIF1alpha in response to hypoxia: their stabilization and redox signal-induced interaction with CBP/p300. EMBO J. 18:1905-1914.
7. Galson, D. L., et al. 1995. The orphan receptor hepatic nuclear factor 4 functions as a transcriptional activator for tissue-specific and hypoxia-specific erythropoietin gene expression and is antagonized by EAR3/COUP-TF1. Mol. Cell. Biol. 15:2135-2144.
8. Godin, I., and A. Cumano. 2005. Of birds and mice: hematopoietic stem cell development. Int. J. Dev. Biol. 49:251-257.
9. Goldberg, M. A., G. A. Glass, J. M. Cunningham, and H. F. Bunn. 1987. The regulated expression of erythropoietin by two human hepatoma cell lines. Proc. Natl. Acad. Sci. U. S. A. 84:7972-7976.
10. Ijpenberg, A., et al. 2007. Wt1 and retinoic acid signaling are essential for stellate cell development and liver morphogenesis. Dev. Biol. 312:157-170.
11. Imagawa, S., et al. 2002. GATA suppresses erythropoietin gene expression through GATA site in mouse erythropoietin gene promoter. Int. J. Hematol. 75:376-381.
12. Jelkmann, W. 2007. Erythropoietin after a century of research: younger than ever. Eur. J. Haematol. 78:183-205.
13. Kapitsinou, P. P., et al. 2010. Hepatic HIF-2 regulates erythropoietic responses to hypoxia in renal anemia. Blood 116:3039-3048.
14. Kobayashi, A., K. Numayama-Tsuruta, K. Sogawa, and Y. Fujii-Kuriyama. 1997. CBP/p300 functions as a possible transcriptional coactivator of Ah receptor nuclear translocator (Arnt). J. Biochem. 122:703-710.
15. Kothary, R., et al. 1989. Inducible expression of an hsp68-lacZ hybrid gene in transgenic mice. Development 105:707-714.
16. Koury, M. J. 2005. Erythropoietin: the story of hypoxia and a finely regulated hematopoietic hormone. Exp. Hematol. 33:1263-1270.
17. Lendahl, U., K. L. Lee, H. Yang, and L. Poellinger. 2009. Generating specificity and diversity in the transcriptional response to hypoxia. Nat. Rev. Genet. 10:821-832.
18. Li, J., G. Ning, and S. A. Duncan. 2000. Mammalian hepatocyte differentiation requires the transcription factor HNF-4alpha. Genes Dev. 14:464-474.
19. Madan, A., C. Lin, S. L. Hatch, and P. T. Curtin. 1995. Regulated basal, inducible, and tissue-specific human erythropoietin gene expression in transgenic mice requires multiple cis DNA sequences. Blood 85:2735-2741.
20. Makita, T., et al. 2001. A developmental transition in definitive erythropoiesis: erythropoietin expression is sequentially regulated by retinoic acid receptors and HNF4. Genes Dev. 15:889-901.
21. Mellor, J. 2006. Dynamic nucleosomes and gene transcription. Trends Genet. 22:320-329.
22. Morita, M., et al. 2003. HLF/HIF-2alpha is a key factor in retinopathy of prematurity in association with erythropoietin. EMBO J. 22:1134-1146.
23. Nakajima, O., et al. 2006. Transgenic rescue of erythroid 5-aminolevulinate synthase-deficient mice results in the formation of ring sideroblasts and siderocytes. Genes Cells 11:685-700.
24. Obara, N., et al. 2008. Repression via the GATA box is essential for tissuespecific erythropoietin gene expression. Blood 111:5223-5232.
25. Oosthuyse, B., et al. 2001. Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat. Genet. 28:131-138.
26. Palis, J. 2008. Ontogeny of erythropoiesis. Curr. Opin. Hematol. 15:155-161.
27. Palis, J., J. Malik, K. E. McGrath, and P. D. Kingsley. 2010. Primitive erythropoiesis in the mammalian embryo. Int. J. Dev. Biol. 54:1011-1018.
28. Parviz, F., et al. 2003. Hepatocyte nuclear factor 4alpha controls the development of a hepatic epithelium and liver morphogenesis. Nat. Genet. 34: 292-296.
29. Pugh, C. W., C. C. Tan, R. W. Jones, and P. J. Ratcliffe. 1991. Functional analysis of an oxygen-regulated transcriptional enhancer lying 3' to the mouse erythropoietin gene. Proc. Natl. Acad. Sci. U. S. A. 88:10553-10557.
30. Rankin, E. B., et al. 2007. Hypoxia-inducible factor-2 (HIF-2) regulates hepatic erythropoietin in vivo. J. Clin. Invest. 117:1068-1077.
31. Ruas, J. L., L. Poellinger, and T. Pereira. 2005. Role of CBP in regulating HIF-1-mediated activation of transcription. J. Cell Sci. 118:301-311.
32. Sasaki, K., and Y. Sonoda. 2000. Histometrical and three-dimensional analyses of liver hematopoiesis in the mouse embryo. Arch. Histol. Cytol. 63: 137-146.
33. Semenza, G. L. 2001. Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology. Trends. Mol. Med. 7:345-350.
34. Semenza, G. L., S. T. Koury, M. K. Nejfelt, J. D. Gearhart, and S. E. Antonarakis. 1991. Cell-type-specific and hypoxia-inducible expression of the human erythropoietin gene in transgenic mice. Proc. Natl. Acad. Sci. U. S. A. 88:8725-8729.
35. Semenza, G. L., M. K. Nejfelt, S. M. Chi, and S. E. Antonarakis. 1991. Hypoxia-inducible nuclear factors bind to an enhancer element located 3' to the human erythropoietin gene. Proc. Natl. Acad. Sci. U. S. A. 88:5680-5684.
36. Semenza, G. L., M. D. Traystman, J. D. Gearhart, and S. E. Antonarakis. 1989. Polycythemia in transgenic mice expressing the human erythropoietin gene. Proc. Natl. Acad. Sci. U. S. A. 86:2301-2305.
37. Shams, I., A. Avivi, and E. Nevo. 2004. Hypoxic stress tolerance of the blind subterranean mole rat: expression of erythropoietin and hypoxia-inducible factor 1 alpha. Proc. Natl. Acad. Sci. U. S. A. 101:9698-9703.
38. Socolovsky, M. 2007. Molecular insights into stress erythropoiesis. Curr. Opin. Hematol. 14:215-224.
39. Suzuki, N., N. Obara, and M. Yamamoto. 2007. Use of gene-manipulated mice in the study of erythropoietin gene expression. Methods Enzymol. 435:157-177.
40. Suzuki, N., et al. 2002. Erythroid-specific expression of the erythropoietin receptor rescued its null mutant mice from lethality. Blood 100:2279-2288.
41. Suzuki, N., et al. 2003. Identification and characterization of 2 types of erythroid progenitors that express GATA-1 at distinct levels. Blood 102: 3575-3583.
42. Takahashi, S., et al. 1997. Arrest in primitive erythroid cell development caused by promoter-specific disruption of the GATA-1 gene. J. Biol. Chem. 272:12611-12615.
43. Takeda, K., et al. 2008. Regulation of adult erythropoiesis by prolyl hydroxylase domain proteins. Blood 111:3229-3235.
44. Togashi, T., M. Obata, Y. Aoyagi, R. Kominami, and Y. Mishima. 2004. Two distinct methods analyzing chromatin structure using centrifugation and antibodies to modified histone H3: both provide similar chromatin states of the Rit1/Bcl11b gene. Biochem. Biophys. Res. Commun. 313:489-495.
45. Wang, F., et al. 2004. Roles of Brahma and Brahma/SWI2-related gene 1 in hypoxic induction of the erythropoietin gene. J. Biol. Chem. 279:46733-46741.
46. Wang, G. L., and G. L. Semenza. 1993. Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia. J. Biol. Chem. 268:21513-21518.
47. Warnecke, C., et al. 2004. Differentiating the functional role of hypoxiainducible factor (HIF)-1alpha and HIF-2alpha (EPAS-1) by the use of RNA interference: erythropoietin is a HIF-2alpha target gene in Hep3B and Kelly cells. FASEB J. 18:1462-1464.
48. Wu, H., X. Liu, R. Jaenisch, and H. F. Lodish. 1995. Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell 83:59-67.
49. Zanjani, E. D., J. L. Ascensao, P. B. McGlave, M. Banisadre, and R. C. Ash. 1981. Studies on the liver to kidney switch of erythropoietin production. J. Clin. Invest. 67:1183-1188.
50. Zaret, K. S. 2002. Regulatory phases of early liver development: paradigms of organogenesis. Nat. Rev. Genet. 3:499-512.
51. Zhao, R., and S. A. Duncan. 2005. Embryonic development of the liver. Hepatology 41:956-967.